Cargando…
The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation
Raloxifene is a selective estrogen receptor modulator typically prescribed for the prevention/treatment of osteoporosis in postmenopausal women. Although raloxifene is known to have anti-inflammatory properties, its effects on human neutrophils, the primary phagocytic leukocytes of the immune system...
Autores principales: | Flores, Roxana, Döhrmann, Simon, Schaal, Christina, Hakkim, Abdul, Nizet, Victor, Corriden, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141331/ https://www.ncbi.nlm.nih.gov/pubmed/28003814 http://dx.doi.org/10.3389/fimmu.2016.00566 |
Ejemplares similares
-
Inhibition of Human Neutrophil Extracellular Trap (NET) Production by Propofol and Lipid Emulsion
por: Meier, Angela, et al.
Publicado: (2019) -
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
por: Papayannopoulos, Venizelos, et al.
Publicado: (2010) -
Dexmedetomidine does not directly inhibit neutrophil extracellular trap production
por: Corriden, Ross, et al.
Publicado: (2022) -
PRAK Is Required for the Formation of Neutrophil Extracellular Traps
por: Wang, Yan, et al.
Publicado: (2019) -
Influences of Chloride and Hypochlorite on Neutrophil Extracellular Trap Formation
por: Akong-Moore, Kathryn, et al.
Publicado: (2012)